Cooley advised Cholesgen on the deal. Cholesgen (Shanghai) Co.Ltd. announced an exciting new collaboration to advance research and development in hypercholesterolemia and related metabolic diseases with...
Cholesgen’s Research Collaboration and Licensing Agreement with AstraZeneca
Seven and Eight Biopharmaceuticals’ License Agreement with Eikon Therapeutics
Cooley advised Seven and Eight Biopharmaceuticals on the deal. Seven and Eight Biopharmaceuticals Inc. announced that it has signed an exclusive licensing agreement with Eikon Therapeutics....
Impact Therapeutics’ Global Partnership with Eikon Therapeutics
Cooley advised Impact Therapeutics on the deal. Impact Therapeutics and Eikon Therapeutics announced that the companies have entered into a global license and collaboration agreement for PARP1 selective inhibitors...
Ionis Pharmaceuticals’ $575 Million Convertible Senior Notes Offering
Cooley advised Ionis Pharmaceuticals on the offering. Ionis Pharmaceuticals, a biotechnology company, announced the offering of $575 million aggregate principal amount of convertible senior notes, including the exercise...
Snyk’s Acquisition of Enso Security
Cooley advised Snyk on the deal. Snyk announced it agreed to acquire Enso Security, pioneers of the industry’s first Application Security Posture Management (ASPM) solution. The...
2045’s $4.2 Million Pre-Seed Funding Round
Cooley advised 2045 on the financing. 2045, an exclusive membership network for influential professionals of color, announced its launch and $4.2 million pre-seed financing. Benchstrength led the...
Tools For Humanity’s $115 Million Series C Funding Round
Cooley advised Tools For Humanity on the financing. Tools for Humanity, the technology company behind Worldcoin, announced that it has raised $115 million in series C...
QED Investors’ $925 Million Funds Formation
Cooley advised QED Investors on the fundraising. QED Investors announced the closing of two new funds with combined capital commitments of $925 million. The new capital...
Veritone’s $52 Million Acquisition of Broadbean
Cooley is acting as legal counsel to Veritone, and Sidley Austin is acting as legal counsel to Career Builder. Veritone, Inc. (NASDAQ: VERI) announced its agreement...
Neo’s $235 Million Funds Formation
Cooley advised Neo on the fundraising. Neo announced the closing of two funds totaling $235 million. Neo will invest $180 million in seed deals and accelerator...
Plymouth Growth’s $125 Million Fifth Fund Formation
Cooley advised Plymouth Growth on the fundraising. Plymouth Growth announced its closing of Plymouth Growth V, LP, with approximately $125 million in committed capital. Plymouth Fund...
m]x[v Capital’s $52 Million Debut Fund Formation
Cooley advised m]x[v Capital on the fundraising. m]x[v Capital announced the closing of its $52 million debut fund. Proceeds from the debut fund will be used to...